• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌治疗并发症的管理

Management of complications of prostate cancer treatment.

作者信息

Michaelson M Dror, Cotter Shane E, Gargollo Patricio C, Zietman Anthony L, Dahl Douglas M, Smith Matthew R

机构信息

Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.

出版信息

CA Cancer J Clin. 2008 Jul-Aug;58(4):196-213. doi: 10.3322/CA.2008.0002. Epub 2008 May 23.

DOI:10.3322/CA.2008.0002
PMID:18502900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2900775/
Abstract

Prostate cancer is the most commonly diagnosed noncutaneous cancer in men in the United States. Treatment of men with prostate cancer commonly involves surgical, radiation, or hormone therapy. Most men with prostate cancer live for many years after diagnosis and may never suffer morbidity or mortality attributable to prostate cancer. The short-term and long-term adverse consequences of therapy are, therefore, of great importance. Adverse effects of radical prostatectomy include immediate postoperative complications and long-term urinary and sexual complications. External beam or interstitial radiation therapy in men with localized prostate cancer may lead to urinary, gastrointestinal, and sexual complications. Improvements in surgical and radiation techniques have reduced the incidence of many of these complications. Hormone treatment typically consists of androgen deprivation therapy, and consequences of such therapy may include vasomotor flushing, anemia, and bone density loss. Numerous clinical trials have studied the role of bone antiresorptive therapy for prevention of bone density loss and fractures. Other long-term consequences of androgen deprivation therapy may include adverse body composition changes and increased risk of insulin resistance, diabetes, and cardiovascular disease. Ongoing and planned clinical trials will continue to address strategies to prevent treatment-related side effects and improve quality of life for men with prostate cancer.

摘要

前列腺癌是美国男性中最常被诊断出的非皮肤癌。前列腺癌男性患者的治疗通常包括手术、放疗或激素治疗。大多数前列腺癌男性患者在确诊后能存活多年,可能永远不会出现因前列腺癌导致的发病或死亡。因此,治疗的短期和长期不良后果非常重要。根治性前列腺切除术的不良反应包括术后即刻并发症以及长期的泌尿和性功能并发症。局部前列腺癌男性患者接受外照射或近距离放射治疗可能会导致泌尿、胃肠和性功能并发症。手术和放疗技术的改进降低了许多此类并发症的发生率。激素治疗通常包括雄激素剥夺疗法,这种疗法的后果可能包括血管舒缩性潮红、贫血和骨密度降低。众多临床试验研究了骨吸收抑制疗法在预防骨密度降低和骨折方面的作用。雄激素剥夺疗法的其他长期后果可能包括不良的身体成分变化以及胰岛素抵抗、糖尿病和心血管疾病风险增加。正在进行和计划中的临床试验将继续探讨预防治疗相关副作用并改善前列腺癌男性患者生活质量的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/5f424c6154b7/nihms-204601-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/d0171ad01aab/nihms-204601-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/5778871f1060/nihms-204601-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/5f424c6154b7/nihms-204601-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/d0171ad01aab/nihms-204601-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/5778871f1060/nihms-204601-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b99d/2900775/5f424c6154b7/nihms-204601-f0003.jpg

相似文献

1
Management of complications of prostate cancer treatment.前列腺癌治疗并发症的管理
CA Cancer J Clin. 2008 Jul-Aug;58(4):196-213. doi: 10.3322/CA.2008.0002. Epub 2008 May 23.
2
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.局部前列腺癌主动监测、手术、近距离放疗或外照射放疗联合或不联合雄激素剥夺治疗 5 年的患者报告结局。
JAMA. 2020 Jan 14;323(2):149-163. doi: 10.1001/jama.2019.20675.
3
Locally advanced prostate cancer: effective treatments, but many adverse effects.局部晚期前列腺癌:治疗有效,但不良反应众多。
Prescrire Int. 2013 Jan;22(134):18-20, 22-3.
4
Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.系统评价:临床局限性前列腺癌治疗方法的比较效果与危害
Ann Intern Med. 2008 Mar 18;148(6):435-48. doi: 10.7326/0003-4819-148-6-200803180-00209. Epub 2008 Feb 4.
5
Evolution of definitive external beam radiation therapy in the treatment of prostate cancer.前列腺癌根治性外照射放疗的演变。
World J Urol. 2020 Mar;38(3):565-591. doi: 10.1007/s00345-019-02661-6. Epub 2019 Mar 8.
6
Management of complications of androgen deprivation therapy in the older man.老年男性雄激素剥夺治疗并发症的管理
Crit Rev Oncol Hematol. 2009 Jun;70(3):235-55. doi: 10.1016/j.critrevonc.2008.09.004. Epub 2008 Oct 25.
7
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.局限性前列腺癌的治疗:根据其自然病程(通常进展相对缓慢),可选择观察等待、手术或放射治疗。
Prescrire Int. 2012 Oct;21(131):242-8.
8
Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.前列腺癌男性雄激素剥夺治疗相关的主要长期副作用风险。
Pharmacotherapy. 2018 Oct;38(10):999-1009. doi: 10.1002/phar.2168. Epub 2018 Sep 4.
9
Functional Outcomes After Localized Prostate Cancer Treatment.局限性前列腺癌治疗后的功能结局。
JAMA. 2024 Jan 23;331(4):302-317. doi: 10.1001/jama.2023.26491.
10
Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.局限性前列腺癌初始治疗后的长期健康相关生活质量:来自 CaPSURE 登记处的结果。
Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18.

引用本文的文献

1
130 Genders and Counting: On Scientific Fact and Trans Livability.130种性别与计数:论科学事实与跨性别者的生存状况
Arch Sex Behav. 2025 Aug 13. doi: 10.1007/s10508-025-03222-2.
2
Evaluating less-invasive strategies for localized prostate cancer: a comparative meta-analysis on high-intensity focused ultrasound versus radical prostatectomy.评估局限性前列腺癌的微创治疗策略:高强度聚焦超声与根治性前列腺切除术的比较荟萃分析
Int Urol Nephrol. 2025 Jul 31. doi: 10.1007/s11255-025-04695-9.
3
The lived experiences and unmet needs of prostate and colorectal male cancer survivors in rural Virginia: A qualitative study.

本文引用的文献

1
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.前列腺癌促性腺激素释放激素激动剂治疗期间的代谢变化:与经典代谢综合征的差异。
Cancer. 2008 May 15;112(10):2188-94. doi: 10.1002/cncr.23440.
2
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
3
Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer.
弗吉尼亚州农村地区前列腺癌和结直肠癌男性幸存者的生活经历与未满足的需求:一项定性研究。
J Rural Health. 2025 Mar;41(2):e12897. doi: 10.1111/jrh.12897. Epub 2024 Nov 10.
4
A narrative review on synchronous concurrent versus delayed sequential surgery in the artificial urinary sphincter and penile prosthesis implantation.关于人工尿道括约肌和阴茎假体植入术中同步并发手术与延迟序贯手术的叙述性综述。
Transl Androl Urol. 2024 Aug 31;13(8):1650-1656. doi: 10.21037/tau-23-22. Epub 2024 Apr 25.
5
Delayed-onset lumbosacral polyradiculitis following proton precision beam therapy for localized prostate cancer: A case report.质子精确束治疗局限性前列腺癌后迟发性腰骶部多神经根炎:一例报告。
Interv Pain Med. 2023 Sep 29;2(4):100281. doi: 10.1016/j.inpm.2023.100281. eCollection 2023 Dec.
6
'Just because I have prostate cancer doesn't mean that I can't do things' - men's experiences of the acceptability of an exercise intervention for prostate cancer during treatment.“我得了前列腺癌,但这并不意味着我什么都做不了”——男性在治疗期间对前列腺癌运动干预可接受性的体验。
BMC Cancer. 2024 Aug 2;24(1):949. doi: 10.1186/s12885-024-12687-8.
7
Racial and socioeconomic disparities in surgical care for post-prostate cancer treatment complications: A nationwide Medicare-based analysis.前列腺癌治疗并发症手术护理中的种族和社会经济差异:一项基于全国医疗保险的分析。
BJUI Compass. 2024 Feb 29;5(6):564-575. doi: 10.1002/bco2.342. eCollection 2024 Jun.
8
Six-Month Prostate Cancer Empowerment Program (PC-PEP) Improves Urinary Function: A Randomized Trial.为期六个月的前列腺癌赋权计划(PC-PEP)改善了排尿功能:一项随机试验。
Cancers (Basel). 2024 Feb 27;16(5):958. doi: 10.3390/cancers16050958.
9
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer.局限性前列腺癌放射治疗的现状。
Curr Oncol. 2023 Sep 1;30(9):8092-8110. doi: 10.3390/curroncol30090587.
10
The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy.SGLT2 抑制剂卡格列净抑制前列腺癌细胞生长并增强其对放射治疗的敏感性。
Commun Biol. 2023 Sep 8;6(1):919. doi: 10.1038/s42003-023-05289-w.
局限性前列腺癌外照射放疗后前列腺体积较大时的毒性特征。
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):83-9. doi: 10.1016/j.ijrobp.2007.05.051. Epub 2007 Sep 12.
4
Laparoscopic radical prostatectomy: surgical, oncological and functional outcomes.腹腔镜根治性前列腺切除术:手术、肿瘤学及功能学结果
Scand J Urol Nephrol. 2008;42(1):29-34. doi: 10.1080/00365590701561879. Epub 2007 Sep 11.
5
Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.经会阴在直肠前脂肪中注射透明质酸,以降低前列腺癌患者接受调强近距离放疗或外照射放疗时直肠的放射性毒性。
Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):95-102. doi: 10.1016/j.ijrobp.2007.02.034.
6
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer.雄激素剥夺疗法会增加前列腺癌男性患者的心血管疾病发病率。
Cancer. 2007 Oct 1;110(7):1493-500. doi: 10.1002/cncr.22933.
7
Contribution of early intensive prolonged pelvic floor exercises on urinary continence recovery after bladder neck-sparing radical prostatectomy: results of a prospective controlled randomized trial.早期强化延长盆底肌锻炼对保留膀胱颈根治性前列腺切除术后尿失禁恢复的作用:一项前瞻性对照随机试验的结果
Neurourol Urodyn. 2007;26(7):985-9. doi: 10.1002/nau.20442.
8
Management of the complications of radical prostatectomy.根治性前列腺切除术并发症的管理
Curr Urol Rep. 2007 May;8(3):197-202. doi: 10.1007/s11934-007-0006-8.
9
Conservative management for postprostatectomy urinary incontinence.前列腺切除术后尿失禁的保守治疗
Cochrane Database Syst Rev. 2007 Apr 18(2):CD001843. doi: 10.1002/14651858.CD001843.pub3.
10
The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy.海绵体神经的发现与保留神经的耻骨后根治性前列腺切除术的发展。
J Urol. 2007 May;177(5):1632-5. doi: 10.1016/j.juro.2007.01.012.